Use of medicinal plants in the diabetes treatment


Use of medicinal plants in the diabetes treatment


Aparecido Jonanthan Mandú de Araújo1,2, Amanda Virgínia Barbosa2, Francisco Henrique da Silva1, Rafael Artur Queiroz Cavalcanti de Sá2, Sivoneide Maria da Silva2, Bárbara de Azevedo Ramos3, Matheus Alves Siqueira de Assunção4, Márcia Vanuza da Silva1, Maria Tereza dos Santos Correia1

1Department of Pharmacy, Federal University of Pernambuco, Recife, Pernambuco, Brazil
2Department of Biochemistry, Federal University of Pernambuco, Recife, Pernambuco, Brazil
3Department of Antibiotics, Federal University of Pernambuco,  Recife, Pernambuco, Brazil
4Department of Histology and Embryology, Federal University of Pernambuco, Recife, Pernambuco, Brazil


Medicinal plants have been used by the population since the beginning as a tool to prevent and fight diseases. In addition, to strengthening local culture and offering cheaper labor, this practice is an alternative to conventional therapies. The use of these plants in metabolic disorders has been studied worldwide. It has shown promising results in reducing glycemic levels and profiles related to diabetes, such as LDL lipid profile, total cholesterol, triglycerides, and glycated hemoglobin (HbA1c). These results can be potential sources for pharmacological treatments, through the production of medicines, as well as the implementation of these plants in the diet, dispensing with the use of commercialized drugs.


Keywords: Phytotherapy, diabetes, dyslipidemia


Free Full-text PDF


How to cite this article:
Aparecido Jonanthan Mandú de Araújo, Amanda Virgínia Barbosa, Francisco Henrique da Silva, Rafael Artur Queiroz Cavalcanti de Sá, Sivoneide Maria da Silva, Bárbara de Azevedo Ramos, Matheus Alves Siqueira de Assunção, Márcia Vanuza da Silva, Maria Tereza dos Santos Correia. Use of medicinal plants in the diabetes treatment. Journal of Herbal Medicine Research, 2020,5:43. DOI: 10.28933/jhmr-2020-08-1205


References:

1. Rempel, C, Maciel, MJ, Bergmann, PC, Morás, AP, Goettens, C. Efeito antimicrobiano de plantas medicinais: uma revisão de estudos científicos. Revista Ibero-Americana de Ciências Ambientais; 2019. v.10, n.4, p.57-82.
2. Brasil. Plantas Medicinais e Fitoterápicos no SUS. Ministério da Saúde. Disponível em: https://www.saude.gov.br/acoes-e-programas/programa-nacional-de-plantas-medicinais-e fitoterapicos-ppnpmf/plantas-medicinais-e-fitoterapicos-no-sus. Acesso: 23 de março de 2020.
3. ANVISA. AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Boletim Saúde e Economia nº 6. Disponível em: http://portal.anvisa.gov.br/publicacoes12?tagsName=dislipidemia. 2011. Acesso: 15 de maio de 2020.
4. Pereira, R. A relação entre Dislipidemia e Diabetes Mellitus tipo 2. Cadernos UniFOA. 2011.
5. ANVISA. AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Diabetes: o que é, tipos, sintomas e tratamento. Disponível em: https://saude.gov.br/component/content/article/746-saude-de-a-a-z/44609-diabetes-tipos-causas-sintomas-tratamento-e-prevencao. 2019. Acesso: 15 de maio de 2020.
6. FioCruz. Taxa de incidência de diabetes cresceu 61,8% nos últimos 10 anos. Disponível em: https://portal.fiocruz.br/noticia/taxa-de-incidencia-de-diabetes-cresceu-618-nos-ultimos-10-anos. 2018. Acesso: 11 de maio de 2020.
7. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103(2): 137-49.
8. Srinivasan, K. Fenugreek (Trigonella foenum-graecum): A Review of Health Beneficial Physiological Effects. Food Reviews Inter-national. 2006. 22(2), 203–224
9. Zameer, S, Najmi, AK, Vohora, D, Akhtar, M. A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological dis-orders: Complementary roles to its hypoli-pidemic, hypoglycemic, and antioxidant po-tential. Nutritional Neuroscience. 2017. p.1–7.
10. Geberemeskel, GA; Debebe, YG; Nguse, NA. Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients. Journal of Diabetes Research. 2019.
11. Sharma RD, Raghuram TC, “Hypoglycaemic effect of fenugreek seeds in non-insulin de-pendent diabetic subjects,”. Nutrition Re-search. 1990. vol. 10, no. 7, pp. 731–739.
12. Deep, G, Dasgupta, T, Rao, AR, Kale, RK. Cancer preventive potential of Momordica charantia L. against benzo(a)pyrene induced fore-stomach tumourigenesis in murine model system. Indian Journal of Experi-mental Biology. 2004. v. 6, n. 3, p.319-322.
13. Leung L, Birtwhistle R, Kotecha J, Hannah, S, Cthbertson, S. Antidiabetic and hypogly-caemic effects of Momordica charantia (bit-ter melon): A mini review. British Journal of Nutrition. 2009. 102:1703–1708
14. Krawinkel MB, Ludwig C, Swai ME, Yang R, Chun KP, Habicht SD. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania. Journal of Ethnopharmacological. 2018.
15. Jayaprakasha, G. e LJM Rao, Química, biogênese e atividades biológicas de Cinnamomum zeylanicum. Revisões críticas em ciência e nutrição de alimentos. 2011. 51 (6): p. 547-562
16. Essid, R, Hammami, M, Gharbi, D, Karkouch, I, Hamouda, TB, Elkahouis, S. et al. Mecanismo antifúngico da combinação de óleos essenciais de Cinnamomum verum e Pelargonium graveolens com fluconazol contra cepas patogênicas de Candida. Appl Microbiol Biotechnol. 2017. 101, 6993–7006.
17. Zare R, Najarzadeh A, Zarshenas MM, Shams M, Heydari M.w Efficacy of Cinna-mon in Patients with Type II Diabetes Melli-tus: A Randomized Controlled Clinical Trial. Clinical Nutrition (2018).
18. Imparl-Radosevich, J., et al., Regulation of PTP-1 and insulin receptor kinase by frac-tions from cinnamon: implications for cin-namon regulation of insulin signalling. Hor-mone Research in Paediatrics, 1998. 50(3): p. 177-182.
19. Golmohammadi, E., S. Mahmazi, M. Rahne-ma, Cinnamon hydro alcoholic extract in-creased expression level of UCP3 gene in skeletal muscle of obese male Wistar Rats. BioRxiv, 2017.
20. Ganguly, S. Indian ayurvedic and traditional medicinal implications of indigenously avail-able plants, herbs and fruits: A review. Int. J. Res. Ayurveda Pharm. 2013, 4, 623–625.
21. Olayaki, LA; Irekpita, JE; Yakubu, MT; Ojo O, O Extrato metanólico de folhas de Moringa oleifera melhora tolerância à glicose, síntese de glicogênio e metabolismo lipídico em ratos diabéticos induzidos por aloxana. J. Basic Clin.Physiol. Pharmacol. 2015. 26, 585–593.
22. Popoola, JO; Obembe, O. O Conhecimento local, padrão de uso e distribuição geográfica de Moringa oleifera Lam. (Moringaceae) na Nigéria. J. Eth-nopharmacol. 2013, 150, 682-691
23. Leone, A, Spada, A, Battezzati, A, Schiraldi, A, Aristil, J, Bertoli, S. Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview. International Journal of Mo-lecular Sciences. 2015. 16(12), 12791–12835.
24. Leone, A, Bertoli, S, Lello, AD, Bassoli, A, Ravasenghi, S, Borgonovo, G, et al. Effect of Moringa oleifera Leaf Powder on Post-prandial Blood Glucose Response: In Vivo Study on Saharawi People Living in Refugee Camps. Nutrients. 2018. V. 10, p. 1494.
25. Hosseinzadeh H, Ziaee T, Sadeghi A. O efeito do estigma de açafrão Crocus sativus , extrato e seus constituintes, safranal e crocina sobre comportamentos sexuais em ratos machos nor-mais. Fitomedicina. 2008; 15 : 491–495.
26. Rios J, Recio M, Giner R, Manez S. Uma revisão atualizada do açafrão e seus constituintes ativos. Phytother Res. 1996; 10 : 189–193
27. Hariri AT, Moallem SA, Mahmoudi M, Memar B, Hosseinzadeh H. Efeitos subagudos do diazinon nos índices bioquímicos e biomarcadores específicos em ratos: efeitos protetores da crocina e safranal. Food Chem Toxicol. 2010; 48 : 2803-2808.
28. Khorasany AR, Hosseinzadeh H. Therapeutic effects of saffron (Crocus sativus L.) in di-gestive disorders: a review. Iran J Basic Med Sci. 2016;19(5):455‐469.
29. Aleali, AM, Amani, R., Shahbazian, H, Nam-jooyan, F, Latifi, SM, Cheraghian, B. The ef-fect of hydroalcoholic Saffron (Crocus sa-tivus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes melli-tus: A randomized double‐blind clinical trial. 2019. Phytotherapy Research. P. 1-10.
30. López, RES, Santos, BC. Bauhinia forficata Link (Fabaceae) Revista Fitos. 2015. Vol, 9(3), 161-252.
31. Mariángel, PC, Lorca, MA, Leon, FM, Rocca, PF, Zapata, LV, Navarrete, EP. Effects of Bauhinia forficata Link Tea on Lipid Profile in Diabetic Patients. Journal of Medicinal Food. 2019.
32. Cechinel-Zanchett, CC, Andrade, SF, Cechi-nel-Filho, V. Ethnopharmacological, Phyto-chemical, Pharmacological and Toxicologi-cal Aspects of Bauhinia forficata: A Mini-Review Covering the Last Five Years. Natural Product Communications, 2018. 13(7)
33. Ahmed M, Shikha HA, Sadhu SK, Rahman MT, Datta BK. Analgesic, diuretic, and anti-inflammatory principle from Scoparia dulcis. Die Pharmazie. 2001 Aug;56(8):657-660.
34. Yisa, Jonathan. Phytochemical Analysis and Antimicrobial Activity Of Scoparia Dulcis and Nymphaea Lotus. Australian Journal of Basic and Applied Sciences, 2009. 3(4): 3975-3979.
35. Senadheera, SPA, Ekanayake, S, Wan-igatunge, C. Anti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics – a randomized crosso-ver clinical trial. BMC Complementary and Al-ternative Medicine. 2015. 15(1).
36. Pari L, Latha M. Efeito anti- hiperlipidêmico de Scoparia dulcis (Sweet Broomweed) em ratos diabéticos com estreptozotocina. J Med Food. 2006.
37. Akhondzadeh, S, Noroozian, M, Moham-madi, M, Ohadinia, S, Jamshidi, A, Khani, M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, place-bo-controlled trial. J. Neurol. Neurosurg. Psychiatry. 2003;74;863-866.
38. Kennedy, DO, Andrew B, Scholey, NTJ, Til-desley, EK, Perry, KA. Wesnes. Modulation of mood and cognitive performance follow-ing acute administration of Melissa offici-nalis (lemon balm). Pharmacology, Biochem-istry and Behavior 72 (2002) 953–964.
39. Asadi, A, Shidfar, F, Safari, M, Hosseini, AF, Fallah Huseini, H, Heidari, I, Rajab, A. Efficacy of Melissa officinalis L. (lemon balm) extract on glycemic control and cardi-ovascular risk factors in individuals with type 2 diabetes: A randomized, double‐blind, clin-ical trial. Phytotherapy Research. 2018.
40. Rehman, R, Akram, M, Akhtar, N, Jabeen, Q, Saeed, T, Shah, SMA, et. al. Zingiber offici-nale Roscoe (pharmacological activity). Journal of Medicinal Plants Research. 2011. Vol. 5(3), pp. 344-348
41. Shidfar, F, Rajab, A, Rahideh, T, Khandouzi, N, Hosseini, S, Shidfar, S. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. Journal of Complementary and Integrative Medicine. 2015. 12(2).
42. Coelho, MS, Salas-Mellado, MM. Revisão: Composição química, propriedades funcionais e aplicações tecnológicas da semente de chia (Salvia hispanica L) em alimentos. Brazilian Journal of Food Tech-nology, 2014, 17(4), 259-268
43. Vuksan, V, Jenkins, AL, Brissette, C, Choleva, L, Jovanovski, E, Gibbs, AL, Han-na, A. Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind random-ized controlled trial. Nutrition, Metabolism and Cardiovascular Diseases. 2017. 27(2), 138–146.
44. ANJOS, F.B.R. Estudo da atividade antidiabética e outros efeitos farmacológicos relativos a pata de vaca (B. monandra Kurz). Dissertação de Mestrado. Universidade Federal de Pernambuco. 1995.48 p.